BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 31888566)

  • 1. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
    BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
    Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
    Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
    BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.
    Truchot Y; Dagher E; Abadie J; Nguyen F
    Front Vet Sci; 2020; 7():622019. PubMed ID: 33553286
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
    Caliari D; Zappulli V; Rasotto R; Cardazzo B; Frassineti F; Goldschmidt MH; Castagnaro M
    BMC Vet Res; 2014 Sep; 10():185. PubMed ID: 25249140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
    Guiu S; Charon-Barra C; Vernerey D; Fumoleau P; Campone M; Spielmann M; Roché H; Mesleard C; Arnould L; Lemonnier J; Lacroix-Triki M
    Future Oncol; 2015; 11(16):2283-97. PubMed ID: 26260807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
    Guiu S; Mollevi C; Charon-Barra C; Boissière F; Crapez E; Chartron E; Lamy PJ; Gutowski M; Bourgier C; Romieu G; Simony-Lafontaine J; Jacot W
    Br J Cancer; 2018 Jul; 119(1):76-79. PubMed ID: 29880907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
    Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M
    Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 represses the molecular phenotype of basal breast cancer cells.
    Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
    Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
    Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
    J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
    Soares M; Correia J; Peleteiro MC; Ferreira F
    Tumour Biol; 2016 Mar; 37(3):4053-64. PubMed ID: 26486327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
    BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
    Liu N; Niu Y; Wang SL; Yu Q; Zhang RJ; Liu TJ
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1403-7. PubMed ID: 20646630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas.
    Sommerville L; Howard J; Evans S; Kelly P; McCann A
    Vet Comp Oncol; 2022 Jun; 20(2):535-538. PubMed ID: 35006637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
    Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
    BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.
    Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R
    BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of androgen receptor and forkhead-box A1 protein in apocrine breast carcinoma.
    Sasahara M; Matsui A; Ichimura Y; Hirakata Y; Murata Y; Marui E
    Anticancer Res; 2014 Mar; 34(3):1261-7. PubMed ID: 24596370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXA1 is an independent prognostic marker for ER-positive breast cancer.
    Mehta RJ; Jain RK; Leung S; Choo J; Nielsen T; Huntsman D; Nakshatri H; Badve S
    Breast Cancer Res Treat; 2012 Feb; 131(3):881-90. PubMed ID: 21503684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.